| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President, Head Of R&D | Chief Executive Officer
4 companies
Morrison Briggs is a Director at ARVN with holdings across 4 companies. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2020 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Buy | 12,500 | $8.00 | $100,000.00 | +39.8% | |
| Oct 10, 2019 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Buy | 11,000 | $5.40 | $59,400.00 | +53.9% | |
| May 13, 2019 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Buy | 20,400 | $7.46 | $152,242.80 | +154.5% |